FDA Backs Immutep’s Eftilagimod Registrational Trial In Metastatic Breast Cancer
Immutep Limited (NASDAQ: IMMP) has
Immutep Announced Australian Patent Granted for Eftilagimod Alpha, a Soluble Lag-3 Protein, in Combination With a PD-1 Pathway Inhibitor
Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep" or "the Company"), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune disease, is pleased to announce the grant of a new patent (number 2016205983) entitled "Combined Preparations for the Treatment of Cancer or Infection" by the Australian Patent Office.
Immutep Reports Good Safety From First Five Patients In Triple Combination Therapy Efti Study, Insight-003
Immutep Limited ((ASX: IMM, NASDAQ:IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune disease, announces
Immutep Reports On Safety From First 5 Patients In Triple Combo Therapy Study, INSIGHT-003
Immutep Limited ((ASX: IMM, NASDAQ:IMMP) ("Immutep” or
“the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments
for cancer and autoimmune disease,
Immutep Granted Chinese Patent For Eftilagimod Alpha, A Soluble Lag-3 Fusion Protein, In Combination With A PD-1 Pathway Inhibitor
Immutep Limited ((ASX: IMM, NASDAQ:IMMP) ("Immutep" or "the Company"), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune disease, is
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
Here's a roundup of top developments in the biotech space over the last 24 hours.
75 Biggest Movers From Yesterday
Gainers
Society Pass Incorporated (NASDAQ: SOPA) surged 436.7% to settle at $48.30 on Tuesday after the company priced its IPO at $9 per share.
58 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Dover Motorsports, Inc. (NYSE: DVD) shares climbed 60.3% to $3.59 after Speedway Motorsports announced it will acquire the company for $3.61 per share in cash.